Vitamin D3 affects the HIV reservoir in humans
Thirty PLHIV in Melbourne took part in the randomised, placebo-controlled VIVA trial. Researchers looked to see if 24 weeks of
Thirty PLHIV in Melbourne took part in the randomised, placebo-controlled VIVA trial. Researchers looked to see if 24 weeks of
Sydney researchers are leading a study to discover more about the HIV reservoir. The TRESAX study seeks to find out
HIV infection takes a heavy toll on the gut. The virus enters the body and heads straight for the stomach
Scientists at the Lewis Katz School of Medicine at Temple University in Philadelphia have designed a gene-editing system that may
Sangamo Biosciences’ efforts to develop genetic therapies for HIV have had some early success, with two of three participants in